Xiamen Voke Mold & Plastic Engineering (301196) Fundamentals 2026 — P/E 39.4x, Revenue Analysis | SniperIQ
Xiamen Voke Mold & Plastic Engineering (301196) is a CN-listed Industrials company in Manufacturing - Miscellaneous with a market capitalization of ¥13.0B, trading at ¥79.24 on the SHZ. This SniperIQ fundamentals page covers Xiamen Voke Mold & Plastic Engineering's valuation (P/E 39.4x, P/B 3.0x), profitability (net margin 11.0%), revenue (¥2.2B in FY2025), balance-sheet quality, and AI signal context — from live market data, research only.
Full research coverage
- 8-Quarter Revenue & Margin Trend
- Debt Maturity & Coverage
- Peer Valuation Comparison
- Free Cash Flow & Owner Earnings
- AI Signal + Institutional Flow
- DCF Valuation Model
Frequently Asked Questions
What is Xiamen Voke Mold & Plastic Engineering's market cap?
Xiamen Voke Mold & Plastic Engineering (301196) has a market capitalization of approximately ¥13.0B, trading at ¥79.24 on the SHZ. Market cap moves with the live share price.
What is Xiamen Voke Mold & Plastic Engineering's P/E ratio?
Xiamen Voke Mold & Plastic Engineering's trailing twelve-month P/E ratio is 39.4x, with a price-to-book (P/B) of 3.0x. Valuation multiples are best compared with Industrials sector peers rather than read in isolation.
How profitable is Xiamen Voke Mold & Plastic Engineering?
Xiamen Voke Mold & Plastic Engineering runs a net profit margin of 11.0%, a gross margin of 28.9%, and an operating margin of 12.1%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
How much revenue does Xiamen Voke Mold & Plastic Engineering generate?
Xiamen Voke Mold & Plastic Engineering reported revenue of ¥2.2B for fiscal year 2025, with net income of ¥257M and earnings per share (EPS) of 2.06. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.
Does Xiamen Voke Mold & Plastic Engineering pay a dividend?
Xiamen Voke Mold & Plastic Engineering offers a trailing dividend yield of about 1.6%. Dividend sustainability depends on payout ratio, free cash flow, and earnings stability — all tracked in SniperIQ's fundamentals view.
Is Xiamen Voke Mold & Plastic Engineering financially healthy?
Xiamen Voke Mold & Plastic Engineering carries a debt-to-equity ratio of 0.02x and a current ratio of 3.88x, with a market beta of 0.53. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
Is Xiamen Voke Mold & Plastic Engineering a good stock to buy in 2026?
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For Xiamen Voke Mold & Plastic Engineering (301196) the key facts are: market cap ¥13.0B, P/E 39.4x, revenue ¥2.2B, 52-week range 52.93846-164.23077. Weigh valuation, profitability, growth, and balance-sheet strength against Industrials peers and form your own view.
Track Xiamen Voke Mold & Plastic Engineering's full fundamentals live
Get Xiamen Voke Mold & Plastic Engineering's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.